Yimei Li Selected Research

Yimei Li Research Topics

Disease

41	Neoplasms (Cancer) 12/2022 - 01/2012
15	Neuroblastoma 05/2022 - 01/2013
14	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 08/2013
13	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2021 - 01/2014
10	Leukemia 01/2022 - 04/2013
9	Medulloblastoma 01/2022 - 04/2012
8	Craniopharyngioma (Craniopharyngiomas) 12/2022 - 09/2015
7	Brain Neoplasms (Brain Tumor) 07/2022 - 04/2012
5	Pain (Aches) 01/2022 - 01/2018
5	Infections 09/2015 - 04/2010
4	Neoplasm Metastasis (Metastasis) 05/2022 - 01/2019
4	Glioma (Gliomas) 01/2022 - 04/2012
4	Diffuse Intrinsic Pontine Glioma 03/2020 - 01/2019
3	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 11/2013
3	Neutropenia 10/2021 - 12/2014
3	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 02/2018
3	Sickle Cell Anemia (Hemoglobin S Disease) 11/2017 - 01/2012
2	Lymphoma (Lymphomas) 10/2021 - 06/2012
2	Fever (Fevers) 10/2021 - 12/2014
2	Malnutrition (Nutritional Deficiencies) 04/2020 - 02/2018
2	Primitive Neuroectodermal Tumors (PNET) 10/2018 - 04/2012
2	Human Influenza (Influenza) 12/2015 - 01/2012
2	Cysts 09/2015 - 09/2011
2	Cardiotoxicity 04/2015 - 04/2013
2	Sepsis (Septicemia) 02/2014 - 06/2013
2	Myeloid Leukemia (Leukemia, Myelocytic) 04/2013 - 03/2013
2	Anaphylaxis (Anaphylactic Shock) 07/2012 - 09/2011
1	Hypothyroidism 12/2022
1	Diabetes Insipidus 12/2022
1	Disease Resistance 10/2022
1	Graves Disease (Basedow Disease) 03/2022
1	Acute Pain 01/2022
1	Lung Diseases (Lung Disease) 01/2022
1	Death (Near-Death Experience) 01/2022
1	Pathologic Constriction (Stenosis) 01/2022
1	Neurofibromatoses (Neurofibromatosis) 01/2022
1	Hodgkin Disease (Hodgkin's Disease) 01/2022
1	Cataract (Cataracts) 01/2022
1	Intractable Pain 11/2021
1	Hypoxia (Hypoxemia) 10/2021
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2021
1	Acute Lung Injury 10/2021
1	Central Nervous System Diseases (CNS Diseases) 10/2021
1	Cytokine Release Syndrome 10/2021
1	Bacteremia 10/2021

Drug/Important Bio-Agent (IBA)

6	Protons (Proton)IBA 07/2022 - 02/2018
6	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2021
5	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 01/2016
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 08/2013
5	dipinacoline glutamateIBA 03/2020 - 05/2014
4	tisagenlecleucelIBA 01/2022 - 10/2021
3	Opioid Analgesics (Opioids)IBA 01/2022 - 01/2018
2	Growth Hormone (Somatotropin)IBA 01/2022 - 01/2020
2	Isotretinoin (Accutane)FDA LinkGeneric 09/2021 - 10/2018
2	EpitopesIBA 01/2021 - 10/2013
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2013
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2020
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020 - 04/2017
2	GlucocorticoidsIBA 01/2019 - 01/2018
2	RacivirIBA 01/2018 - 11/2015
2	Prednisone (Sone)FDA LinkGeneric 01/2018 - 01/2016
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2018 - 01/2016
2	ribociclibIBA 04/2017 - 11/2013
2	AntigensIBA 05/2015 - 09/2011
2	AnthracyclinesIBA 04/2015 - 04/2013
2	Dexrazoxane (Zinecard)FDA LinkGeneric 04/2015 - 04/2013
2	Proteins (Proteins, Gene)FDA Link 10/2013 - 01/2002
2	VaccinesIBA 01/2012 - 04/2010
1	Hormones (Hormone)IBA 12/2022
1	Dihydrotachysterol (AT 10)IBA 12/2022
1	GTP-Binding Proteins (G-Protein)IBA 10/2022
1	Thyroid HormonesIBA 03/2022
1	Methionine (L-Methionine)FDA Link 01/2022
1	CeramidesIBA 01/2022
1	CD19-specific chimeric antigen receptorIBA 01/2022
1	Carbon MonoxideIBA 01/2022
1	Ketamine FDA LinkGeneric 01/2022
1	Cytochromes c (Cytochrome c)IBA 01/2022
1	Lidocaine (Xylocaine)FDA LinkGeneric 11/2021
1	Morphine (MS Contin)FDA LinkGeneric 11/2021
1	tocilizumab (atlizumab)FDA Link 10/2021
1	CytokinesIBA 10/2021
1	rhodiolosideIBA 10/2021

Therapy/Procedure

37	Therapeutics 05/2022 - 08/2009
28	Drug Therapy (Chemotherapy) 05/2022 - 04/2012
24	Radiotherapy 12/2022 - 06/2013
7	Proton Therapy 03/2022 - 09/2015
5	Cell Transplantation 07/2021 - 11/2017
4	Aftercare (After-Treatment) 12/2022 - 09/2012
4	Induction Chemotherapy 05/2022 - 03/2013
4	Transplantation 01/2022 - 01/2019
4	Hematopoietic Stem Cell Transplantation 01/2021 - 11/2013
4	Critical Care (Surgical Intensive Care) 01/2018 - 02/2014
3	Length of Stay 01/2019 - 10/2014
2	Maintenance Chemotherapy 05/2022 - 10/2021
2	Craniospinal Irradiation 01/2021 - 04/2012
2	Retreatment 01/2021 - 01/2020
2	Adjuvant Chemotherapy 01/2021 - 12/2019
1	Patient-Controlled Analgesia (Analgesia, Patient Controlled) 11/2021
1	Treatment Delay 10/2021